Exogenous neural stem cell transplantation for cerebral ischemia
Cerebral ischemic injury is the main manifestation of stroke, and its incidence in stroke patients is 70–80%. Although ischemic stroke can be treated with tissue-type plasminogen activator, its time window of effectiveness is narrow. Therefore, the incidence of paralysis, hypoesthesia, aphasia, dysp...
Main Authors: | Ling-Yi Liao, Benson Wui-Man Lau, Dalinda Isabel Sánchez-Vidaña, Qiang Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=7;spage=1129;epage=1137;aulast=Liao |
Similar Items
-
Spreading depression and focal venous cerebral ischemia enhance cortical neurogenesis
by: Ryo Tamaki, et al.
Published: (2017-01-01) -
Nonhuman primate models of focal cerebral ischemia
by: Jingjing Fan, et al.
Published: (2017-01-01) -
Oligodendrogenesis after Cerebral Ischemia
by: Ruilan eZhang, et al.
Published: (2013-10-01) -
Bone marrow mesenchymal stem cells transplantation promotes the release of endogenous erythropoietin after ischemic stroke
by: Wen Lv, et al.
Published: (2015-01-01) -
Spatiotemporal expression of Nogo-66 receptor after focal cerebral ischemia
by: Yue Cao, et al.
Published: (2016-01-01)